Back to mobile site

Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss of $0.68

May 8, 2025 5:21 PM EDT

Rapport Therapeutics, Inc. (NASDAQ: RAPP) reported Q1 EPS of ($0.68).

For earnings history and earnings-related data on Rapport Therapeutics, Inc. (RAPP) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK